# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-034146
Filing Date
2024-03-20
Accepted
2024-03-20 16:00:52
Documents
75
Period of Report
2023-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | vor-20231231.htm iXBRL | 10-K | 2686416
2 | EX-23.1 | vor-ex23_1.htm | EX-23.1 | 7683
3 | EX-31.1 | vor-ex31_1.htm | EX-31.1 | 13603
4 | EX-31.2 | vor-ex31_2.htm | EX-31.2 | 15146
5 | EX-32.1 | vor-ex32_1.htm | EX-32.1 | 17650
| Complete submission text file | 0000950170-24-034146.txt |  | 9365305

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | vor-20231231.xsd | EX-101.SCH | 1192178
78 | EXTRACTED XBRL INSTANCE DOCUMENT | vor-20231231_htm.xml | XML | 1530282

Mailing Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140
Business Address 100 CAMBRIDGEPARK DRIVE SUITE 101 CAMBRIDGE MA 02140 617-655-6580
Vor Biopharma Inc. (Filer) CIK: 0001817229 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39979 | Film No.: 24767739
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)